Company: KROS
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001664710-25-000018
Chunk: 36

Company: Keros Therapeutics, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 7A
Chunk 36
---
raJasbir Seehra, Ph.D.Chief Executive Officer(Principal Executive Officer)

POWER OF ATTORNEY AND SIGNATURES

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Jasbir Seehra, Ph.D., and Keith Regnante, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the U.S. Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and either of them, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NAMETITLEDATE/s/ Jasbir SeehraChief Executive Officer and Director(Principal Executive Officer)February 26, 2025Jasbir Seehra, Ph.D./s/ Keith RegnanteChief Financial Officer(Principal Financial Officer and Principal Accounting Officer)February 26, 2025Keith Regnante/s/ Jean-Jacques BienaiméDirectorFebruary 26, 2025Jean-Jacques Bienaimé/s/ Nima FarzanDirectorFebruary 26, 2025Nima Farzan/s/ Carl GordonDirectorFebruary 26, 2025Carl Gordon, Ph.D., C.F.A./s/ Mary Ann GrayDirectorFebruary 26, 2025Mary Ann Gray, Ph.D./s/ Tomer KarivDirectorFebruary 26, 2025Tomer Kariv/s/ Julius KnowlesDirectorFebruary 26, 2025Julius Knowles/s/ Ran NussbaumDirectorFebruary 26, 2025Ran Nussbaum/s/ Alpna SethDirectorFebruary 26, 2025Alpna Seth